The haematological malignancies patient report outcomes (HM-PRO) measure has been developed to support patients and their clinicians in discussing, addressing and better recording quality of life issues that matter patients.
Common Terminology Criteria for Adverse Events (CTCAE) is widely accepted as the standard classification and severity grading scale for adverse events in cancer therapy, clinical trials and other oncology settings. Version 5.0 is the most updated document (November 27, 2017)
European Organisation for Research and Treatment of Cancer (EORTC) assessment of quality of life of myeloma patients.
European Organisation for Research and Treatment of Cancer (EORTC) assessment of quality of life of cancer patients involving a 30 item questionnaire.
The British Pain Society has provided a pain rating scale to assist with the assessment of pain.
The Lawton Instrumental Activities of Daily Living (IADL) scale assesses the more complex activities of daily living necessary for living in the community, such as shopping, cooking and managing finances. These skills are usually lost before other activities of daily living functions are, such as bathing, dressing and eating.
The Eastern Cooperative Oncology Group (ECOG) performance status is a scale used to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.
The Brief Fatigue Inventory is a simple yet sensitive tool that allows the severity and impact of cancer-related fatigue to be assessed.
